Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Personal stories

Personal stories

J&J Impact Ventures invests in Rology to expand access to critical, high-quality radiology diagnostics

By advancing innovative teleradiology solutions, more patients receive the critical imaging interpretations they need—when and where they need them most.

Bridging the Gap: New J&J CareCommunity collaborations support 70,000 health workers across Latin America

By investing in health workers and local infrastructure, J&J CareCommunity is helping strengthen communities and expand access to care across Latin America.

Accelerating impact: The acquisition of CareAcademy by Activated Insights

With the acquisition, more health workers across the U.S. will be able to access a comprehensive learning platform to develop new skills.

Moving toward a more personalized approach to treating depression

The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

J&J Impact Ventures invests in ThinkMD, increasing the availability and accuracy of clinical decision-making at the point of care

What if any healthcare worker—regardless of training, tenure or location—could be empowered with adaptive tools that enable them to conduct high-quality clinical assessments?

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.

5 ways Johnson & Johnson is innovating in medicines and therapies

From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.